Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Arcadia Biosciences (RKDA) Cost of Revenue (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Cost of Revenue readings, the most recent being $709000.0 for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 14.27% to $709000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.1 million, a 4.59% increase, with the full-year FY2025 number at $3.1 million, up 4.56% from a year prior.
  • Cost of Revenue hit $709000.0 in Q4 2025 for Arcadia Biosciences, down from $884000.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $3.8 million in Q4 2021 to a low of $178000.0 in Q4 2023.
  • Median Cost of Revenue over the past 5 years was $841500.0 (2021), compared with a mean of $1.3 million.
  • Biggest five-year swings in Cost of Revenue: surged 548.48% in 2021 and later tumbled 81.14% in 2023.
  • Arcadia Biosciences' Cost of Revenue stood at $3.8 million in 2021, then plummeted by 76.03% to $900000.0 in 2022, then plummeted by 80.22% to $178000.0 in 2023, then skyrocketed by 364.61% to $827000.0 in 2024, then fell by 14.27% to $709000.0 in 2025.
  • The last three reported values for Cost of Revenue were $709000.0 (Q4 2025), $884000.0 (Q3 2025), and $824000.0 (Q2 2025) per Business Quant data.